/Companies

JUMPCODE Genomics

San Diego, US · Founded 2016 · Delaware corporation · 7 employees on LinkedIn · 4 known investors

Find your way into JUMPCODE Genomics

Sign up to see every warm intro you have to JUMPCODE Genomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the JUMPCODE Genomics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers. Its technology is used in basic research, infectious disease, oncology, and consumer genomics.

Founders & leadership

DM
David Michael SalterExecutive
MSMike Salter
Mike SalterCEO/PresidentPreviously CEO of EKF Diagnostics, where he also served as President Americas and CEO Americas, and before that held commercial and general management roles at GE Healthcare, including USCAN Sales Director for custom molecular biology and diagnostics. He has served as a non-executive director at Trellus Health since 2021.
EC
Eugene ChenNamed on SEC filing
KB
Keith BrownNamed on SEC filing
JR
Joel RotroffNamed on SEC filing

Board

CT
Court TurnerBoard directorPartner at LYZZ Capital
JL
Joseph LeeBoard director
KMKirk Malloy
Kirk MalloyBoard directorPhD at Arboretum Ventures

Investors · 4

Reported raises · per SEC filings

Form D private placements

$38.7M disclosed across 5 rounds · 2018–2024

▶$3.5MraisedAug 2024 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David Michael SalterExecutive Officer, Director
  • Court TurnerDirector
  • Joseph LeeDirector
Offering amount
$11.5M
Amount sold
$3.5M
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.2MraisedMay 2023 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yaron HakakExecutive Officer, Director
  • Frank WitneyDirector
  • Court TurnerDirector
  • Kirk MalloyDirector
  • Dan KidleDirector
  • Brandon PoeExecutive Officer
Offering amount
$16.1M
Amount sold
$9.2M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedDec 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith BrownExecutive Officer
  • Yaron HakakExecutive Officer, Director
  • Dan KidleDirector
  • Kirk MalloyDirector
  • Kevin LiDirector
  • Frank WitneyDirector
  • Michael LiangDirector
Offering amount
$21M
Amount sold
$21M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedFeb 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Keith BrownExecutive Officer, Director
  • Eugene ChenDirector
  • Kevin LiDirector
  • Joel RotroffDirector
  • Kirk MalloyDirector
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedSep 2018 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Eugene ChenDirector
  • Keith BrownExecutive Officer, Director
  • Joel RotroffDirector
  • Kirk MalloyDirector
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through JUMPCODE Genomics went on to found or lead other companies.

Related companies · 4

Companies working in the same space as JUMPCODE Genomics.

Frequently asked questions

What does JUMPCODE Genomics do?
Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers. Its technology is used in basic research, infectious disease, oncology, and consumer genomics.
Who are JUMPCODE Genomics's investors?
JUMPCODE Genomics's investors include Arboretum Ventures, Baird Capital, Global Health Investment Corporation, LYZZ Capital.
How much funding has JUMPCODE Genomics raised?
JUMPCODE Genomics has disclosed $38.7M raised across 5 rounds.
Where is JUMPCODE Genomics headquartered?
JUMPCODE Genomics is headquartered in San Diego, US.